(19)
(11) EP 3 673 956 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
30.08.2023 Bulletin 2023/35

(45) Mention of the grant of the patent:
26.07.2023 Bulletin 2023/30

(21) Application number: 19219614.5

(22) Date of filing: 24.12.2019
(51) International Patent Classification (IPC): 
A61N 5/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61N 5/103

(54)

SYSTEMS AND METHODS FOR TREATMENT PLANNING USING CONTINUOUS QUALITY METRICS

SYSTEME UND VERFAHREN ZUR BEHANDLUNGSPLANUNG MIT KONTINUIERLICHEN QUALITÄTSMETRIKEN

SYSTÈMES ET PROCÉDÉS DE PLANIFICATION DE TRAITEMENT UTILISANT DES MESURES DE QUALITÉ CONTINUES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 31.12.2018 US 201816237489

(43) Date of publication of application:
01.07.2020 Bulletin 2020/27

(73) Proprietor: Siemens Healthineers International AG
6312 Steinhausen (CH)

(72) Inventors:
  • KUUSELA, Esa
    Helsinki 00270 (FI)
  • HALKO, Lauri Jaakonpoika
    Helsinki 00270 (FI)
  • RUOKOKOSKI, Emmi
    Helsinki 00270 (FI)
  • PELTOLA, Jarkko
    Tuusula, 04300 (FI)

(74) Representative: Foster, Mark Charles et al
Mathisen & Macara LLP Charta House 30-38 Church Street
Staines-upon-Thames, Middlesex TW18 4EP
Staines-upon-Thames, Middlesex TW18 4EP (GB)


(56) References cited: : 
EP-A1- 3 418 926
 WO-A1-2018/122251
   
  • JAN UNKELBACH ET AL: "Optimization approaches to volumetric modulated arc therapy planning", MEDICAL PHYSICS, vol. 42, no. 3, 25 February 2015 (2015-02-25), pages 1367-1377, XP055214578, ISSN: 0094-2405, DOI: 10.1118/1.4908224
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).